Clinical Trial Update: 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigating 68Ga-PSMA-11 PET/MRI for detecting tumors in intermediate- to high-risk prostate cancer patients undergoing surgery, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• 68Ga-PSMA-11 PET/MRI

Snippet

Sponsor: Andrei Iagaru | Conditions: Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-03-04